ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,261, issued on Nov. 18, was assigned to ProLynx LLC (San Francisco).
"Conjugated inhibitors of DNA damage response" was invented by Shaun D. Fontaine (Concord, Calif.), Brian R. Hearn (Moraga, Calif.) and Daniel V. Santi (San Francisco).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are releasable conjugates of inhibitors of DNA damage response suitable for use as therapeutic agents in the treatment of disease."
The patent was filed on Aug. 28, 2020, under Application No. 17/639,234.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2...